This functional link prompted us to investigate if the observed differences in PGC1A expression levels in PBMCs between patients with thyroid carcinoma and hyperplasias (Figure 3) could be also related to mtDNA stability. The gene discussed is PPARGC1A; the disease is thyroid gland carcinoma.